Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 8Breast 6Genitourinary 5Tumor-Agnostic 4Gastrointestinal 4Thoracic 3Other hematologic neoplasm 3Sarcoma 2Plasma cell 2Other solid neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1

Conditions

Neoplasms 4

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Geriatric Assessment × Tumor-Agnostic × Clear all
NCT02000011 2022-11-14

epigac

Assistance Publique Hopitaux De Marseille

Phase NA Completed
50 enrolled
Tumor-Agnostic

Neoplasms

NCT03881137 2022-11-09

Improved Function and Quality of Life for Older Patients Receiving Radiotherapy, Part II

Sykehuset Innlandet HF

Phase NA Completed
178 enrolled
Tumor-Agnostic

Neoplasms

NCT03154671 2022-05-20

Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer

University of Toronto

Phase NA Completed
351 enrolled
Tumor-Agnostic

Neoplasms

NCT02671994 2019-01-04

GOAT

Odense University Hospital

Phase NA Unknown
114 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡